AstraZeneca PLC (Germany) Probability of Future Stock Price Finishing Under 141.45

ZEG Stock  EUR 128.40  2.75  2.10%   
AstraZeneca PLC's future price is the expected price of AstraZeneca PLC instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of AstraZeneca PLC performance during a given time horizon utilizing its historical volatility. Check out AstraZeneca PLC Backtesting, AstraZeneca PLC Valuation, AstraZeneca PLC Correlation, AstraZeneca PLC Hype Analysis, AstraZeneca PLC Volatility, AstraZeneca PLC History as well as AstraZeneca PLC Performance.
  
Please specify AstraZeneca PLC's target price for which you would like AstraZeneca PLC odds to be computed.

AstraZeneca PLC Target Price Odds to finish below 141.45

The tendency of AstraZeneca Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay under € 141.45  after 90 days
 128.40 90 days 141.45 
about 78.57
Based on a normal probability distribution, the odds of AstraZeneca PLC to stay under € 141.45  after 90 days from now is about 78.57 (This AstraZeneca PLC probability density function shows the probability of AstraZeneca Stock to fall within a particular range of prices over 90 days) . Probability of AstraZeneca PLC price to stay between its current price of € 128.40  and € 141.45  at the end of the 90-day period is about 54.3 .
Assuming the 90 days horizon AstraZeneca PLC has a beta of 0.24. This usually means as returns on the market go up, AstraZeneca PLC average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding AstraZeneca PLC will be expected to be much smaller as well. Additionally AstraZeneca PLC has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   AstraZeneca PLC Price Density   
       Price  

Predictive Modules for AstraZeneca PLC

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as AstraZeneca PLC. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
126.48128.40130.32
Details
Intrinsic
Valuation
LowRealHigh
128.11130.03131.95
Details
Naive
Forecast
LowNextHigh
122.86124.78126.70
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
127.19129.53131.88
Details

AstraZeneca PLC Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. AstraZeneca PLC is not an exception. The market had few large corrections towards the AstraZeneca PLC's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold AstraZeneca PLC, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of AstraZeneca PLC within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.17
β
Beta against Dow Jones0.24
σ
Overall volatility
8.76
Ir
Information ratio -0.14

AstraZeneca PLC Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of AstraZeneca PLC for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for AstraZeneca PLC can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
AstraZeneca PLC generated a negative expected return over the last 90 days
AstraZeneca PLC has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
AstraZeneca PLC has accumulated 22.96 B in total debt with debt to equity ratio (D/E) of 179.6, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. AstraZeneca PLC has a current ratio of 0.74, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist AstraZeneca PLC until it has trouble settling it off, either with new capital or with free cash flow. So, AstraZeneca PLC's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like AstraZeneca PLC sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for AstraZeneca to invest in growth at high rates of return. When we think about AstraZeneca PLC's use of debt, we should always consider it together with cash and equity.

AstraZeneca PLC Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of AstraZeneca Stock often depends not only on the future outlook of the current and potential AstraZeneca PLC's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. AstraZeneca PLC's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.5 B

AstraZeneca PLC Technical Analysis

AstraZeneca PLC's future price can be derived by breaking down and analyzing its technical indicators over time. AstraZeneca Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of AstraZeneca PLC. In general, you should focus on analyzing AstraZeneca Stock price patterns and their correlations with different microeconomic environments and drivers.

AstraZeneca PLC Predictive Forecast Models

AstraZeneca PLC's time-series forecasting models is one of many AstraZeneca PLC's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary AstraZeneca PLC's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about AstraZeneca PLC

Checking the ongoing alerts about AstraZeneca PLC for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for AstraZeneca PLC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
AstraZeneca PLC generated a negative expected return over the last 90 days
AstraZeneca PLC has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
AstraZeneca PLC has accumulated 22.96 B in total debt with debt to equity ratio (D/E) of 179.6, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. AstraZeneca PLC has a current ratio of 0.74, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist AstraZeneca PLC until it has trouble settling it off, either with new capital or with free cash flow. So, AstraZeneca PLC's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like AstraZeneca PLC sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for AstraZeneca to invest in growth at high rates of return. When we think about AstraZeneca PLC's use of debt, we should always consider it together with cash and equity.

Other Information on Investing in AstraZeneca Stock

AstraZeneca PLC financial ratios help investors to determine whether AstraZeneca Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AstraZeneca with respect to the benefits of owning AstraZeneca PLC security.